Stuart Paul has served as our President and Chief Executive Officer and a member of Rockwell Medical’s Board of Directors since September 2018.
Mr. Paul has significant operating experience in the healthcare industry, with a successful track record of executing commercialization strategies both domestically and internationally throughout his 25-year career. Previously, Mr. Paul served as Corporate Officer and Vice President of Abbott Laboratories, where he facilitated integration of the Alere acquisition, while leading its largest global business unit with $600 million of revenues. From 2015 to 2017, Mr. Paul served as the Vice President and General Manager of Quest Diagnostics’ U.S. East Region, where he led the turnaround of laboratories, patient services and the commercial business.
From 2007 to 2013, Mr. Paul worked within private equity at Gambro AB, where he was responsible for leading and profitably expanding a variety of businesses, including its Asia-Pacific and Americas Renal therapeutics businesses. Following the successful exit and sale of Gambro AB to Baxter International, Mr. Paul led the integration of the combined Baxter-Gambro Renal business in Latin America, driving further synergies, revenue and profit growth.
Mr. Paul received his bachelor’s degree in chemistry from Duke University and his master’s in marketing and finance from the Kellogg School of Management at Northwestern University.